Adaptive Biotechnologies (ADPT) Gross Profit Growth (1y) (2019 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 40.07% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 8.91% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 6.29% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 45.16% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 27.63% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 57.12% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 6.81% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 77.40% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 25.70% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 22.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.70% |
| Mar 31, 2026 | 47.10% |
| Dec 31, 2025 | 81.74% |
| Sep 30, 2025 | 154.69% |
| Jun 30, 2025 | 71.24% |
| Mar 31, 2025 | 48.87% |
| Dec 31, 2024 | 12.40% |
| Sep 30, 2024 | 60.28% |
| Jun 30, 2024 | -23.03% |
| Mar 31, 2024 | 25.60% |
| Dec 31, 2023 | -32.22% |
| Sep 30, 2023 | -43.59% |
| Jun 30, 2023 | 1.90% |
| Mar 31, 2023 | -25.41% |
| Dec 31, 2022 | 63.78% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | 9.73% |
| Mar 31, 2022 | -10.63% |
| Dec 31, 2021 | -1.62% |
| Sep 30, 2021 | 24.85% |